These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 32611399)

  • 1. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
    BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
    J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
    Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.
    Le W; Zeng CH; Liu Z; Liu D; Yang Q; Lin RX; Xia ZK; Fan ZM; Zhu G; Wu Y; Xu H; Zhai Y; Ding Y; Yang X; Liang S; Chen H; Xu F; Huang Q; Shen H; Wang J; Fogo AB; Liu ZH
    BMC Nephrol; 2012 Nov; 13():158. PubMed ID: 23181565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of the Oxford classification of IgA nephropathy in children.
    Shima Y; Nakanishi K; Hama T; Mukaiyama H; Togawa H; Hashimura Y; Kaito H; Sako M; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2012 May; 27(5):783-92. PubMed ID: 22134880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
    Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
    Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
    Bellur SS; Roberts ISD; Troyanov S; Royal V; Coppo R; Cook HT; Cattran D; Arce Terroba Y; Asunis AM; Bajema I; Bertoni E; Bruijn JA; Cannata-Ortiz P; Casartelli D; Maria Di Palma A; Ferrario F; Fortunato M; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Giannakakis K; Gomà M; Gröne HJ; Gutiérrez E; Asma Haider S; Honsova E; Ioachim E; Karkoszka H; Kipgen D; Maldyk J; Mazzucco G; Orhan D; Ozluk Y; Pantzaki A; Perkowska-Ptasinska A; Riispere Z; Soderberg MP; Steenbergen E; Stoppacciaro A; Sundelin Von Feilitzen B; Tardanico R
    Nephrol Dial Transplant; 2019 Oct; 34(10):1681-1690. PubMed ID: 30561721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
    Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Oxford classification of IgA nephropathy.
    Herzenberg AM; Fogo AB; Reich HN; Troyanov S; Bavbek N; Massat AE; Hunley TE; Hladunewich MA; Julian BA; Fervenza FC; Cattran DC
    Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 30-year follow-up study of IgA nephritis in a Southeast Asian population: an evaluation of the Oxford histological classification
.
    Woo KT; Lim CC; Foo MW; Loh HL; Jin AZ; Chin YM; Choo JC; Tan PH; Chow KY; Choong LH; Tan HK; Wong KS; Chan CM
    Clin Nephrol; 2016 Nov; 86 (2016)(11):270-278. PubMed ID: 27641054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
    J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crescentic IgA nephropathy in children.
    Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
    Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
    Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
    Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
    Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.